2018 AAN Annual Meeting Disclosure Information

In an effort to provide as much information to our attendees as possible, the Meeting Management Committee, with the support and approval of the Education and Science Committees, requires full disclosure of all individuals involved in the 2018 Annual Meeting program, including platform session co-chairs, education program directors and faculty members, science presenters, selected committee and subcommittee members, members of the AAN Board of Directors, and selected AAN staff. This listing contains the relevant disclosure information. This information is kept on file, updated on an annual basis, and reviewed each time an individual contributes to an AAN program.

Read Industry Relations Message

Last Name:

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Showing 1 - 31 of 562 people


Sudhakar R. Satti
(Science Program) (P3)

Dr. R. Satti has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Stryker Neurovascular and Penumbra Neurovascular.


Henitsoa RASOANANDRIANINA
(Science Program) (P3)

Dr. RASOANANDRIANINA has nothing to disclose.


CRISTIANE ROCHA
(Science Program) (S45)

Dr. ROCHA has nothing to disclose.


Joost Raaphorst
(Science Program) (P3, P4)

Dr. Raaphorst has nothing to disclose.


Meheroz Rabadi
(Science Program) (P5)

Dr. Rabadi has nothing to disclose.


Michael Rabbia
(Science Program) (P5)

Dr. Rabbia has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche.


Laura Rabinovich-Guilatt
(Science Program) (P4)

Dr. Rabinovich-Guilatt has nothing to disclose.


Gil Rabinovici
(Science Program, Education Program) (P3, C13, C146, C161, P4)

Dr. Rabinovici has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech and Merck. Dr. Rabinovici has received personal compensation in an editorial capacity for JAMA Neurology. Dr. Rabinovici has received research support from Avid Radiopharmaceuticals, Eli Lilly, GE Healthcare and Piramal.


Alejandro Rabinstein
(Science Program) (P4, S41, P3, P6)

Dr. Rabinstein has nothing to disclose.


Brad Racette
(Education Program) (C159)

Dr. Racette has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Brown and James. Dr. Racette has received research support from U.S. World Meds.


Susan Rachel
(Science Program) (P6)

Dr. Rachel has nothing to disclose.


Tamar Rachmilewitz
(Science Program) (P2, S26)

Dr. Rahmilevich has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with NeuroDerm.


Michael Racke
(Education Program, Science Program) (C122, P2, P3)

Dr. Racke has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Coherus Bioscience and Teva Neuroscience. Dr. Racke has received personal compensation in an editorial capacity for Elsevier as Editor-in-Chief of Journal of Neuroimmunology. Dr. Racke has received research support from Genentech, Novartis, Actelion, TG Therapeutics and Alkermes.


Nazila Rad
(Science Program) (P2)

Dr. Rad has nothing to disclose.


Marta Radaelli
(Science Program) (P2, P3, S37, S6, P6)

Dr. Radaelli has received personal compensation for activities compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck Serono, Sanofi, and Teva.


Rosa Rademakers
(Science Program) (S48, S2, P3)

Dr. Rademakers has nothing to disclose.


Farid Radmanesh
(Science Program) (S1)

Dr. Radmanesh has nothing to disclose.


Sara Radmard
(Science Program) (S41)

Dr. Radmard has nothing to disclose.


Ernst-Wilhelm Radue
(Science Program) (P6)

Dr. Radue has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Actelion, Basilea, Bayer HealthCare, Biogen, Merck Serono, and Novartis. Dr. Radue has received research support from Actelion, Bayer HealthCare, Biogen, Merck Serono, and Novartis.


Batya Radzik
(Science Program) (P4)

Dr. Radzik has nothing to disclose.


Alexander Rae-Grant
(Science Program) (P5)

Dr. Rae-Grant has nothing to disclose.


Gary Rafaloff
(Science Program) (P5)

Dr. Rafaloff has nothing to disclose.


Samia Rafeedie
(Science Program) (P6)

Dr. Rafeedie has nothing to disclose.


Manoj Raghavan
(Science Program) (P1, P2)

Dr. Raghavan has nothing to disclose.


Prashant Raghavan
(Science Program) (P4)

Dr. Raghavan has nothing to disclose.


Kartik Raghupathi
(Science Program) (P3, S36)

Dr. Raghupathi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Celgene.


Victoria Ragland
(Award Winner)


Laura Ragoonanan
(Science Program) (P1)

Dr. Ragoonanan has nothing to disclose.


Michael Ragozzino
(Science Program) (P3)

Dr. Ragozzino has nothing to disclose.


Rahul Rahangdale
(Science Program) (P4, P3, P1, P2)

Dr. Rahangdale has nothing to disclose.


Next >>

For More Information

Jill Zelinsky

Senior Specialist, Annual Meeting and Conference Logistics
(612) 928-6049
jzelinsky@aan.com